Loading...
Thumbnail Image
Publication

Intriguing High Z'' Cocrystals of Emtricitabine

Palanisamy, V.
Sanphui, P.
Bolla, G.
Narayan, Aditya
Seaton, Colin C.
Vangala, Venu R.
Publication Date
2020-08
End of Embargo
Supervisor
Rights
© 2020 ACS. This document is the Accepted Manuscript version of a Published Work that appeared in final form in Crystal Growth & Design, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.cgd.0c00744
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2020-07
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
Emtricitabine (ECB) afforded dimorphic cocrystals (Forms I, II) of benzoic acid (BA), whereas with p-hydroxybenzoic acid (PHBA), p-aminobenzoic acid (PABA) are resulted in as high Z'' cocrystals. Intriguingly, the Z'' of cocrystals are trends from two to fourteen based on the manipulation of functional groups on the para position of BA (where H atom is replaced with that of OH or NH2 group). ECB‒PABA cocrystal consists of six molecules each and two water molecules in the asymmetric unit (Z''=14) with 2D planar sheets represents the rare pharmaceutical cocrystal. The findings suggest that the increment of H bond donor(s) systematically via a suitable coformer are in correspondence with attaining high Z'' cocrystals. Further, solid state NMR spectroscopy in conjunction with single crystal X-ray diffraction are demonstrated as significant tools to enhance the understanding of the number of symmetry independent molecules in the crystalline lattice and provide insights to the mechanistic pathways of crystallization.
Version
Accepted manuscript
Citation
Palanisamy V, Sanphui P, Bolla G et al (2020) Intriguing High Z'' Cocrystals of Emtricitabine. Crystal Growth & Design. 20(8): 4886-4891.
Link to publisher’s version
Link to published version
Type
Article
Qualification name
Notes